AlzeCure Pharma Balance Sheet Health

Financial Health criteria checks 6/6

AlzeCure Pharma has a total shareholder equity of SEK35.5M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK42.6M and SEK7.0M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 39.19m
EquitySEK 35.52m
Total liabilitiesSEK 7.04m
Total assetsSEK 42.56m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: AC6's short term assets (SEK42.4M) exceed its short term liabilities (SEK7.0M).

Long Term Liabilities: AC6 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: AC6 is debt free.

Reducing Debt: AC6 has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AC6 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: AC6 has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 2.6% each year.


Discover healthy companies